2026 CBP ACE & FDA OASIS Enforcement Update: MoCRA Cosmetic FEI & QMSR Device 510(k) Affirmation of Compliance cross-checks are active at Los Angeles, Newark, Miami & Savannah ports.
FEILookup · DWPERadarFEI + OASIS + 483
FDA INDUSTRY CODE 60–66 (Human OTC & Ophthalmic Drugs)5-Yr Detention Rate: 27.1%

Ophthalmic Drops, Nasal Sprays & OTC Monograph Drugs — FDA Port Detention & Violation Breakdown

Sterile artificial tears, ophthalmic lubricants, saline nasal sprays, and topical antiseptic manufacturers under intense FDA cGMP sterility and cleanroom water system scrutiny.

2026 CBP ACE & FDA Division Compliance Enforcement Priority:Pre-entry sterility verification and immediate DWPE placement under Import Alert 66-40 for multi-dose preservative-free eye drop facilities with Form 483 media-fill deficiencies.
5-Yr Refusals Tracked
940
Avg Container Hold
35 Days
Primary Entry Ports
Newark, Miami, Los Angeles
Audited Dossiers
2 Factories

Active DWPE Import Alerts in Ophthalmic & OTC

  • Import Alert 66-40 (Drugs Not Manufactured in Conformity with cGMP)
  • Import Alert 66-79 (Foreign Establishments Refusing FDA Inspection)
  • Import Alert 66-41 (Unapproved New Drugs Marketed as OTC)
Export Full Ophthalmic & OTC Supplier Audit Sheet ($39)

Download the normalized 5-year Excel dataset with FEI/DUNS mappings and FSVP checklists.

Buy Cleaned 5-Yr Excel ($39 • Gumroad Instant Checkout)

Top Cited Statutory Charge Codes & Form FDA 766 Eligibility

Audited Overseas Suppliers in Ophthalmic Drops, Nasal Sprays & OTC Monograph Drugs (2)

Ahmedabad, Gujarat, IndiaFEI: 3015092811

Ahmedabad Sterile Ophthalmics & Pharma Ltd.

100/100

Contract manufacturer of preservative-free carboxymethylcellulose lubricating eye drops and isotonic nasal sprays. Placed on Import Alert 66-40 Red List following a 9-observation Form FDA 483 citing ISO 5 aseptic filling interventions and water-for-injection (WFI) biofilm excursions.

3 Refusals1 Warning Letters1 RecallsNewark
Red List — Import Alert 66-40 (cGMP Sterility Non-Conformity)Open Supplier Dossier
Cheongju (Osong Bio-Health Technopolis), South KoreaFEI: 3022819044

Osong BioPharma Isotonic Labs Co., Ltd.

33/100

Modern Korean sterile hydrogel wound spray, hyaluronic contact lens rewetting drop, and OTC monograph topical analgesic factory. Detained when US private-label distributors omit Drug Facts active ingredient percentages or make non-monograph dry-eye therapeutic claims.

2 Refusals0 Warning Letters0 RecallsSavannah
Yellow List — OTC Monograph Drug Facts & NDC Listing VerificationOpen Supplier Dossier

Ophthalmic & OTC FDA Detention FAQ

What is the average FDA port detention rate and hold duration for Ophthalmic & OTC?

Across 5-year CBP/FDA OASIS records, Ophthalmic Drops, Nasal Sprays & OTC Monograph Drugs (FDA Industry Code 60–66 (Human OTC & Ophthalmic Drugs)) experiences a 27.1% detention rate among flagged overseas shippers with an average port hold of 35 calendar days across Newark, Miami, Los Angeles.

What are the top FDA Charge Codes in Ophthalmic & OTC?

The primary statutory charge codes for Ophthalmic & OTC are INSANITARY_CONDITIONS, UNAPPROVED_NEW_DRUG, UNSAFE_COLOR. Key active Import Alerts include Import Alert 66-40 (Drugs Not Manufactured in Conformity with cGMP); Import Alert 66-79 (Foreign Establishments Refusing FDA Inspection); Import Alert 66-41 (Unapproved New Drugs Marketed as OTC). Historical refusal logs do not certify future admissibility.